Editorial
Copyright ©The Author(s) 2024.
World J Gastroenterol. Apr 21, 2024; 30(15): 2081-2086
Published online Apr 21, 2024. doi: 10.3748/wjg.v30.i15.2081
Figure 1
Figure 1 The complex pathophysiological interplay between metabolic (dysfunction) associated fatty liver disease and renal function. T2D: Type 2 diabetes; FFA: Free fatty acids; MAFLD: Metabolic (dysfunction) associated fatty liver disease; CKD: Chronic kidney disease; ROS: Reactive oxygen species; RNS: Reactive nitrogen species; SCFAs: Short chain fatty acids; TMAOs: Trimethylamine-N-oxides; PNPLA3: Patatin-like phospholipase domain-containing 3; TM6SF2: Transmembrane 6 superfamily member 2; MBOAT7: Membrane-bound O-acyltransferase 7.